RNAZ - Transcode Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RNAZ (1829635)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-09-28
RNAZFitzgerald Thomas ACFOP - Purchase$0.51+49,35056,318+708%+$25,169
2023-09-28
RNAZDudley Robert MichaelCEOP - Purchase$0.51+98,000180,262+119%+$49,980
M
2023-06-20
RNAZDudley Robert MichaelCEOP - Purchase$2.62+18,60782,262+29%+$48,665
A
2023-06-09
RNAZDudley Robert MichaelCEOP - Purchase$2.76+19,00061,155+45%+$52,440
2023-06-09
RNAZDudley Robert MichaelCEOP - Purchase$2.76+19,000912,114+2%+$52,440
2022-09-14
RNAZDudley Robert MichaelCEO, 10%P - Purchase$1.15+20,000893,114+2%+$23,000
2022-06-16
RNAZFitzgerald Thomas ACFOP - Purchase$1.27+12,000139,377+9%+$15,240
M
2022-05-27
RNAZDudley Robert MichaelCEO, 10%P - Purchase$1.85+30,000873,114+4%+$55,383

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top